This session describes Post-COVID Condition (PCC), also known as Long COVID—a persistent and often disabling syndrome that affects individuals after the acute phase of COVID-19. Although the severity of infections has declined since the height of the pandemic, many people continue to experience long-term symptoms, particularly cognitive difficulties, which significantly impact daily life. Access to specialised care remains limited, making evidence-based treatment approaches essential.
It will present findings from a detailed study involving 100 individuals with ongoing cognitive symptoms following COVID-19. This study assessed cognitive performance and examined biological markers of brain damage, inflammation, and potential neurodegenerative processes, offering insight into the mechanisms underlying PCC.
It also shares insights from clinical experience and a systematic review of the current treatment landscape for PCC. The review highlights the limited but emerging evidence supporting various therapeutic strategies and emphasises the urgent need for further research and service development.
Finally, the session will present results from a clinical outcomes study in which patients with PCC were offered Cognitive Behavioural Therapy (CBT). The findings suggest that CBT may provide meaningful benefits for some individuals, particularly in managing psychological distress and improving functional outcomes.
Although the acute threat of COVID-19 has diminished, the long-term effects continue to cause significant disability for many. With few dedicated services available, it is critical to develop and implement evidence-based treatments to support recovery and improve the quality of life for those living with PCC.
Learning objectives
By the end of this webinar you will be able to:
- understand the clinical presentation and describe common symptoms, including cognitive symptoms associated with the post-COVID condition (PCC)
- evaluate the current evidence base for treatments targeting symptoms in PCC.
- critically appraise the effectiveness of CBT in improving outcomes for individuals with PCC.
- apply insights from personal experience and research to inform clinical practice and future research directions.
Speakers
Chair: Dr Muj Husain, Consultant Liaison Psychiatrist, South London and Maudsley NHS Foundation Trust
Professor Alan Carson, University of Edinburgh, Edinburgh
Professor Emeritus Paul Garner, Liverpool School of Tropical Medicine, Liverpool
Professor Trudie Chalder, King's College London, London
Availability
This webinar is part of the Congress webinar 2026 package. If you attended all four days of Congress, you will have access to these as part of your Congress package. Otherwise the Congress webinar 2026 package can be purchased below.
